Abstracts

The Call for Abstracts will begin in February 2025. Submissions must be received via the online submission site by April 4th, 2025 at 11:59 PM CDT. No exceptions will be allowed. Only online submissions made through the submission site will be considered.

• By submitting an abstract to the AAP National Conference & Exhibition, submitters are agreeing to participate as accepted. The decision regarding acceptance and presentation format is final.
• If the submission cannot be presented, the abstract must be withdrawn. Failure to present or withdraw may preclude any author on the submission from submitting to the AAP National Conference for two years. To withdraw your abstract, email your request to abstracts@aap.org . 
• All presenting authors (orals and posters) must register and must attend the 2025 National Conference in-person in Denver, CO. There are no virtual presentations. Presenters are responsible for their own conference registration fees and travel expenses.
• All accepted submissions will be made available to conference attendees and the public following the embargo lift which occurs the Friday that the conference begins.
• Health professionals in any field are welcome to submit abstracts. Some programs may have membership or sponsorship requirements for submission.
• Submissions will be peer-reviewed by representatives of the program under which the abstract is submitted.

• Submissions are allowed in one section/council program only. Duplicate submissions will be a basis for automatic rejection.
• Abstract text is limited to 450 words.
• Abstracts will be published exactly as submitted. No copyediting will be provided by the AAP. Submitters are responsible for thoroughly reviewing their submission and ensuring accuracy before submission (no edits/updates).
• Up to two images and/or tables are permitted (file formats: JPG, PNG, BMP). Image content/text and captions do not count towards word limit.
• The submitter will serve as the primary contact for all correspondence regarding the abstract during the submission process. After an abstract is accepted, the presenting author will serve as the primary contact.
• Only individuals can author a submission. Study groups are not allowed to author a submission and will be removed.
• It is highly encouraged that authors meet the definition of authorship as defined by the International Committee of Medical Journal Editors.
• Geographical location and name of institution and/or study site is permitted only when it is a significant variable to the study.
• Study registration numbers should be included on abstracts, posters, and slides, where applicable.
• Use only standard abbreviations. Special or unusual abbreviations should be placed in parentheses after the first appearance of the full word.

• Advocacy Project: Presenting ongoing or completed novel advocacy efforts related to the promotion of child health. Required headers: Background, Project Description, Discussion, Conclusion
• Case Report: Presenting scientific documentation of a single clinical observation to enhance knowledge on clinical manifestations, diagnostic approaches, or therapeutic alternatives of a rare or unusual clinical condition/disease. Required Headers: Introduction, Case Description, Discussion, Conclusion
• Original Research: Presenting systematic investigation designed to produce new knowledge and approaches using process or outcome variables. If your abstract describes animal experimentation or involves the use of human subjects, IACUC or IRB approval numbers must be included in the submission. Required Headers: Background, Methods, Results, Conclusion.
• Program Evaluation: Presenting ongoing or completed projects, including education programs, showcasing novel and innovative methods for examining and/or improving the effectiveness and efficiency of a program or policy. Required Headers: Background, Methods, Results, Conclusion
• Quality Improvement Project: Presenting approaches to assess and improve professional practice performance using quality improvement methodology. Please see below for MOC details. Required Headers: Purpose/Objectives, Design/Methods, Results, and Conclusion/Discussion

All submissions must provide information about any prior presentation and publication. Please refer to program specific guidelines for any restrictions. For purposes of describing your prior presentation the following definitions will be used:

• Original: The first presentation of this work or data.
• Encore: Original’s data are reproduced except for formatting, word count, or other “trivial” changes for presentation at multiple conferences.
• Adaptation: The content overlaps with the Original, but contains new/additional data, analyses, and/or interpretations.

 2024 PROGRAM-SPECIFIC GUIDELINES

• The presenting author will serve as the main point of contact for the duration of the abstract.
• Poster presenters must create a poster to be on display within the designated poster hall.
• Each poster will be designated for presentation on one day based on the program’s date.
• Poster presenters will have a designated Q&A time to present their work to the public. This time will be available as the meeting approaches.
• Posters should be horizontally oriented, no smaller than 3 feet tall x 4 feet wide (36 inches x 48 inches), and no larger than 4’ tall x 8’ wide (48 inches x 96 inches). Pushpins will be provided.
• Fonts should be sans-serif (e.g., Arial, Calibri, etc.).
• Minimum font size should not be smaller than 6pt.
• All author financial relationships and research funding sources must be present/visible on the poster. If there is nothing to disclose, the poster must include the following: “Authors have no financial relationships to disclose.”
• The presenting author is the only author allowed to submit a poster and participate in the Q&A on-site.
• Changes to presenting authors will be considered until the withdrawal deadline (August 16). Presenting authors may only be changed to an existing co-author or senior author listed on the original submission.
• The American Academy of Pediatrics does not provide printing services onsite.

• All accepted submissions must create a PowerPoint slide deck for the oral presentation and be required to present in person on their section/program’s designated date and time.
• The presenting author is the only author allowed to present, submit slides, and participate in the Q&A. Changes to presenting authors will be considered until the withdrawal deadline (August 16).
• A slide template will be available for the development of slides within the Abstract Portal. PowerPoint slides should be formatted with a 16:9 aspect ratio.
• Each presentation must have a title slide and a second slide disclosing all author financial relationships and research funding sources.
• Slide upload information will be available through the Abstract Portal.
• Presentation minutes and Q/A information will be provided based upon each program within the Abstract Portal.

• All accepted submissions will be able to upload an optional supplemental virtual poster presentation.
• Virtual Poster is limited to one (1) single page PDF in landscape (horizontal) orientation.
• The aspect ratio of the page should be set to 16:9 in PowerPoint and the final version should be saved as a PDF file for upload.
• Virtual posters will be on display in the virtual poster hall. Virtual posters will appear with all abstract listings within the Conference Portal.